We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5333:TSENGK Insulators, Ltd. Analysis

Data as of 2026-05-25 - not real-time

¥6,131.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

NGK Corporation is trading at ¥6,131, comfortably above its 20‑day (¥5,300), 50‑day (¥4,640) and 200‑day (¥3,438) simple moving averages, underscoring a strong bullish bias. The RSI of 78.7 signals an overbought condition, while the MACD histogram of +31.9 and bullish signal line suggest momentum remains positive, though the decreasing volume trend raises caution. Recent price action has been volatile, with a 30‑day volatility of 37% and a beta of only 0.54, indicating the stock moves less than the market but can experience sharp swings. The DCF fair value of ¥4,447 is well below the current price, implying the market may be overvaluing the shares by roughly 17%, a view reinforced by the negative upside/downside projection. Fundamentally, the company delivers solid growth with 11% revenue expansion and maintains a respectable dividend yield of 1.81% supported by a 38% payout ratio and strong cash flow. However, its debt‑to‑equity ratio near 30% and a forward P/E around 30 suggest valuation pressure despite a stable earnings base. Overall, the stock presents a mixed picture of technical strength and fundamental resilience tempered by overvaluation and heightened short‑term risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Decreasing volume trend
  • Potential near‑term correction from overvaluation

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Solid revenue growth and margin profile
  • Sustainable dividend payout
  • Continued bullish technical alignment despite price premium

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified global product portfolio
  • Strong cash generation and manageable debt
  • Long‑term upside from industry tailwinds and dividend stability

Key Metrics & Analysis

Financial Health

Revenue Growth11.10%
Profit Margin8.94%
P/E Ratio29.7
ROE7.81%
ROA4.94%
Debt/Equity29.93
P/B Ratio2.2
Op. Cash Flow¥138.0B
Free Cash Flow¥57.8B
Industry P/E29.7

Technical Analysis

TrendBullish
RSI78.7
Support¥4,322.00
Resistance¥6,148.00
MA 20¥5,300.00
MA 50¥4,640.02
MA 200¥3,438.00
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value¥4,445.87
Target Price¥5,034.29
Upside/Downside-17.89%
GradeOvervalued
TypeBlend
Dividend Yield1.81%

Risk Assessment

Beta0.54
Volatility37.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.